Literature DB >> 10493399

The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.

M Vidailhet1, A M Bonnet, R Marconi, F Durif, Y Agid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10493399

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  5 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Non-human primate models of PD to test novel therapies.

Authors:  Marc Morissette; Thérèse Di Paolo
Journal:  J Neural Transm (Vienna)       Date:  2017-04-08       Impact factor: 3.575

3.  Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.

Authors:  Gali Heimer; Izhar Bar-Gad; Joshua A Goldberg; Hagai Bergman
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

4.  Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.

Authors:  Pedro Barroso-Chinea; Erwan Bezard
Journal:  Front Neuroanat       Date:  2010-09-14       Impact factor: 3.856

Review 5.  Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.

Authors:  Theresa A Zesiewicz; Kelly L Sullivan; Robert A Hauser
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.